Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial (2022)
- Authors:
- USP affiliated authors: KUPA, LEONARD DE VINCI KANDA - FM ; PEREIRA, ROSA MARIA RODRIGUES - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1136/annrheumdis-2021-221916
- Subjects: METOTREXATO; VACINAS VIRAIS; ARTRITE REUMATOIDE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Annals of the rheumatic diseases
- ISSN: 0003-4967
- Volume/Número/Paginação/Ano: v. 81, n. 6, p. 889-897, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
ARAUJO, Carlo Scognamiglio Renner et al. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, v. 81, n. 6, p. 889-897, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221916. Acesso em: 15 maio 2024. -
APA
Araujo, C. S. R., Medeiros-Ribeiro, A. C., Saad, C. G. S., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., et al. (2022). Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, 81( 6), 889-897. doi:10.1136/annrheumdis-2021-221916 -
NLM
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2024 maio 15 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916 -
Vancouver
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2024 maio 15 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916 - SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy
- Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring
- Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome
- Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE
- Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study
- Autoimmune hepatitis in 847 childhood- onset systemic lupus erythematosus population: a multicentric cohort study
- Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: a Brazilian multicenter study
- Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients
- Chronic Arthritis in Systemic Lupus Erythematosus: Distinct Features in 336 Pediatric and 1,830 Adult Patients
- Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients
Informações sobre o DOI: 10.1136/annrheumdis-2021-221916 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
